CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,352 | +70.8% | 11,200 | +166.7% | 0.00% | – |
| Q2 2023 | $9,576 | +150.5% | 4,200 | 0.0% | 0.00% | – |
| Q1 2023 | $3,822 | +7.1% | 4,200 | 0.0% | 0.00% | – |
| Q4 2022 | $3,570 | +19.0% | 4,200 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 4,200 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 4,200 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 4,200 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -50.0% | 4,200 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $20,000 | +81.8% | 4,200 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -15.4% | 4,200 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $13,000 | -13.3% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -11.8% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $17,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |